Novel RNA-Based Liquid Biopsy Test Study for Early Detection of Colorectal Cancer
Hani Goodarzi, PhD
Liquid biopsy is a novel technology with potential high impact in the management of patients undergoing image-guided procedures. IO Learning spoke with Dr Hani Goodarzi, Associate Professor in the Department of Biochemistry & Biophysics and the Department of Urology at the University of California, San Francisco about his recent poster "Serum-Based Colorectal Cancer Detection Using Orphan Noncoding RNAs," which was presented at the 2022 European Society of Medical Oncology (ESMO) meeting.
Related Content
About Us
Vascular Disease Management™ (VDM), the official media partner of the International Symposium on Endovascular Therapy (ISET) and the Amputation Prevention Symposium (AMP), is a peer-reviewed journal that educates readers on the latest advancements in endovascular treatment strategies.
Learn more about ISET and AMP and register for the events here:




